The State of Sickle Cell Disease Care in the United States: How Can Emergency Medicine Contribute?

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

3 citing papers in PubMed.

1. The Bias of Medicine in Sickle Cell Disease.Journal of general internal medicine · 2023
   Article
2. Surveillance for Sickle Cell Disease - Sickle Cell Data Collection Program, Two States, 2004-2018.Morbidity and mortality weekly report. Surveillance summaries (Washington, D.C. : 2002) · 2022
   Article
3. Bounded Justice and the Limits of Health Equity.The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics · 2021
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as